Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11341801 | 0.81 | LMNA (0.57) | LMNATHRB | |
| SCHEMBL4293299 | 0.79 | LMNA (0.71) | LMNATHRB | |
| Acetaldehyde SCHEMBL212729 | 0.79 | LMNA (0.71) | LMNATHRB | |
| SCHEMBL11079148 | 0.79 | LMNA (0.55) | LMNATHRB | |
| SCHEMBL401436 | 0.78 | LMNA (0.60) | LMNATHRB | |
| Propionaldehyde SCHEMBL1523503 | 0.77 | LMNA (0.67) | LMNATHRB | |
| Formic Acid SCHEMBL6366884 | 0.77 | LMNA (0.67) | LMNATHRB | |
| Formamide SCHEMBL856006 | 0.77 | LMNA (0.67) | LMNATHRB | |
| Isobutyraldehyde SCHEMBL427264 | 0.77 | LMNA (0.67) | LMNATHRB | |
| SCHEMBL9789571 | 0.76 | LMNA (0.57) | LMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794492-B2 | N-(2,2,2-TRIFLUOROETHYL)GLYCINE DERIVATIVES; CAN BE USED TO PREPARE LIPOPHILIC PROTEINS ADAPTED FOR CROSSING THE BLOOD BRAIN BARRIER | CLEMSON UNIVERSITY | 2004-09-21 | — | — | US | disclosed |
| US-20010046960-A1 | Novel perfluoroalkyl compounds and their methods of use and manufacture | CLEMSON UNIVERSITY | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010046960-A1 | Novel perfluoroalkyl compounds and their methods of use and manufacture | PFAS, PTMS, QRFPR | LMNA 4284/4885THRB 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.